Pages that link to "Q47444177"

The following pages link to Native HIV type 1 virion surface structures: relationships between antibody binding and neutralization or lessons from the viral capture assay (Q47444177):

Displaying 16 items.

• Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells (Q27320687) (← links)
• In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1 (Q33725718) (← links)
• Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. (Q34434854) (← links)
• Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site (Q35192937) (← links)
• The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization (Q35644971) (← links)
• Identifying epitopes of HIV-1 that induce protective antibodies (Q35708836) (← links)
• Analysis of human monoclonal antibodies generated by dengue virus-specific memory B cells (Q36305202) (← links)
• Molecular determinants of the ratio of inert to infectious virus particles (Q36494676) (← links)
• N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus (Q36565090) (← links)
• Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees (Q36978671) (← links)
• Identification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivation (Q37157165) (← links)
• Antigenic properties of the HIV envelope on virions in solution (Q37547245) (← links)
• Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization (Q39305772) (← links)
• The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles (Q40414065) (← links)
• An unrelated monoclonal antibody neutralizes human immunodeficiency virus type 1 by binding to an artificial epitope engineered in a functionally neutral region of the viral envelope glycoproteins (Q42086489) (← links)
• Topological analysis of HIV-1 glycoproteins expressed in situ on virus surfaces reveals tighter packing but greater conformational flexibility than for soluble gp120. (Q42572387) (← links)